Greater use of in-patient diagnostic imaging improves patient outcomes without significantly impacting costs

Oct 28, 2009

Hospitals that make greater use of inpatient diagnostic imaging exams achieve lower in-hospital mortality rates with little or no impact on costs, according to a peer-reviewed study of more than 1 million patient outcomes in more than 100 hospitals nationwide published in the November issue of the Journal of the American College of Radiology (JACR).

"The results of our in-depth study would indicate that greater use of imaging does, in fact, lead to better patient outcomes in terms of lower in-hospital death rates with no significant impact on overall cost," said David W. Lee, Ph.D., lead author of the article and Senior Director, Health Economics and Outcome Research at GE Healthcare. "This study dealt only with imaging provided in hospitals, but would seem to confirm what many have long suspected — that medical imaging exams save lives."

Researchers examined data from the Thomson Reuters Drug Database (HDD) exploring the association between the utilization of diagnostic imaging services and two key hospital outcome measures: mortality and costs. Their analysis examined data from inpatient admissions that occurred during 2007 in the 102 hospitals in the HDD that provided sufficiently detailed data to support assessment of the utilization of inpatient diagnostic services. The study included all clinical conditions treated in-hospital, assessing the experience of patients with private, commercial and governmental-sponsored insurance.

"Because use of imaging procedures grew rapidly in the early parts of this decade, payers and policymakers have questioned whether more use is associated with better health outcomes. Based on our research, the answer would appear to be yes," said Lee.

Source: American Roentgen Ray Society

Explore further: German Merck to buy St. Louis-based Sigma-Aldrich

add to favorites email to friend print save as pdf

Related Stories

Recommended for you

German Merck to buy St. Louis-based Sigma-Aldrich

14 hours ago

German drug company Merck says it has agreed to buy St. Louis-based chemical firm Sigma-Aldrich Corp. for $17 billion in a deal Merck says will strengthen its business in chemicals and laboratory equipment.

The human race evolved to be fair for selfish reasons

Sep 19, 2014

"Make sure you play fairly," often say parents to their kids. In fact, children do not need encouragement to be fair, it is a unique feature of human social life, which emerges in childhood. When given the o ...

User comments : 0